TopFunds

Topicus

NASDAQ: TOI

Stock price

5.13 USD

(-48.18%) 5 years

softwareMedical - Care Facilities

Insider Transactions

5Y price score: (66)
Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

5Y return: -48.18%
DATE RANGE:
USD PER SHARE

  • Stock price
  • Sales
  • Purchases
  • Stock awards

Transaction History

Trade log
DateActionSharesPriceShare ValueHoldingNameTitleSource
27-jul.-26Award33,133--205,716Kaushal Mohitdirectorlink
27-jul.-26Award41,165--332,535McGeorge Annedirectorlink
27-jul.-26Award30,120--286,881Pacala Mark Ldirectorlink
27-jul.-26Award31,124--56,957STOLPER MARKdirectorlink
27-jul.-26Award29,116--46,301TZOUMAKAS KIMBERLY JOdirectorlink
27-jul.-26Award27,108--710,829Hively Braddirectorlink
27-jul.-26Award31,124--319,410Johnson Karen Mariedirectorlink
21-jul.-26Purchase18,0005.394,86010,648,858Chernett Jorey10 percent ownerlink
14-jul.-26Sale(17,974)6.4(115,555)259,527Podnos Yaleofficer: Chief Medical Officerlink
14-jul.-26Sale(5,478)6.4(34,785)259,527Podnos Yaleofficer: Chief Medical Officerlink

2.3

52-week range

6.6

5.13

Your model inputs

Required return / cost of capital
%
FCFF terminal growth rate
%

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Set price notification

Valuation

Free Cash Flow Yield

Help
FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

(0.1) %

Dividend Yield TTM

-

Market cap $

512.9

Price / Earnings TTM

Help
P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

(18.3)

Price / Book TTM

(28.8)

PEG TTM

Help
Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

(0.8)

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

27.3 %

(48.2) %

(47.1) %

Free cash flow per share growth

187.5 %

(159.2) %

-

Earnings per share growth

46.7 %

(125) %

-

Analyst ratings

Price Target Low

7

Price Target High

10

Price Target Median

9

Buy

5

Hold

0

Sell

0

Financials

all figures in USD Millions except per share data

Periods:

View:

Forecast:

Help

Averages

based on historical growth rates (CAGR) and average margins for last 10 or max, available and up to 10 years.

Analysts

Average Revenue and Net Income forecast estimates from analysts who cover the stock.

Custom

you can edit default forecast based on averages or analysts consensus and use it to calculate fair value based on your assumptions.

ㅤ

Actual
10 year gagr
Estimated
Projected
Fiscal
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
2026
2027
2028
2029
2030
Terminal
FISCAL PERIOD END DATES
SHOW FORECAST VS ACTUAL
01Earnings per share
Help
Diluted EPSLearn more
0.1
(0.1)
(0.2)
(0.2)
(0.2)
(0.9)
(0.7)
(0.5)
-
-
-
-
-
-
-
02FCF per share
0.1
-
-
(0.5)
(0.8)
(0.6)
(0.4)
-
-
-
-
-
-
-
-
03Dividends per share
Help
Adjusted for splitsLearn more
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
04Dividends payout, %
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
05Revenue
113.2
155.4
187.5
203
252.5
324.2
393.4
502.7
23.7%
622.1
769.8
952.6
1,179
1,459
1,502
06ㅤ% Change
-
37.3%
20.7%
8.3%
24.4%
28.4%
21.3%
27.8%
23.7%
23.7%
23.7%
23.7%
23.7%
23.7%
23.7%
07Net Income
3.9
(4)
(14.3)
(10.9)
0.2
(83.1)
(64.7)
(60.6)
-
(51.5)
(63.7)
(78.8)
(97.5)
(120.6)
(124.3)
08ㅤ% Margin
3.5%
(2.6)%
(7.6)%
(5.4)%
0.1%
(25.6)%
(16.4)%
(12.1)%
(8.3)% A
(8.3)%
(8.3)%
(8.3)%
(8.3)%
(8.3)%
(8.3)%
09CFO
5.6
3.6
0.5
(32.7)
(61.8)
(36.3)
(26.5)
(24.6)
-
(43.4)
(53.7)
(66.5)
(82.2)
(101.8)
(104.8)
10ㅤ% Of revenue
5%
2.3%
0.3%
(16.1)%
(24.5)%
(11.2)%
(6.8)%
(4.9)%
(7)% A
(7)%
(7)%
(7)%
(7)%
(7)%
(7)%
11CAPEX
(0.7)
(1.2)
(1.2)
(3)
(5.5)
(4.6)
(3.8)
(3.2)
24.4%
(4)
(4.9)
(6.2)
(7.7)
(9.5)
(11.8)
12ㅤ% Change
-
73.1%
(0.9)%
155.2%
81.5%
(17.4)%
(17)%
(15.5)%
24.4% A
24.4%
24.4%
24.4%
24.4%
24.4%
24.4%
13FCFF
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities (09) – Capital Expenditures (11)Learn more
4.9
2.4
(0.7)
(35.7)
(67.3)
(40.9)
(30.3)
(27.8)
-
(47.4)
(58.7)
(72.6)
(89.9)
(111.3)
(116.6)
14Total assets
-
59.5
65.7
203.4
261.7
209.2
172.7
164.7
18.5%
∞
∞
∞
∞
∞
∞
15ㅤ% Change
-
∞%
10.4%
209.7%
28.6%
(20)%
(17.5)%
(4.7)%
∞%
∞%
∞%
∞%
∞%
∞%
∞%
16Total liabilities
-
17.3
37.6
99.3
138.5
152.2
169.1
180.4
47.8%
∞
∞
∞
∞
∞
∞
17ㅤ% Of assets
-
29.1%
57.2%
48.8%
52.9%
72.8%
97.9%
109.6%
109.6% A
109.6%
109.6%
109.6%
109.6%
109.6%
109.6%
18Shareholders Equity
-
42.2
28.1
104.2
123.2
57
3.6
(15.7)
∞%
-
-
-
-
-
-
19Net Debt
-
(2.4)
5.9
(114.1)
94.2
86.2
73.5
70.1
-
-
-
-
-
-
-
20Shares Outstanding
Help
Diluted Weighted-average Shares OutstandingLearn more
64,446
64,446
59,118
66,231
80,606
73,749
75,044
923,894
46.3%
1,351,529
1,977,101
2,892,226
4,230,927
6,189,262
9,054,037
21ㅤ% Change
-
-
(8.3)%
12%
21.7%
(8.5)%
1.8%
1,131.1%
46.3%
46.3%
46.3%
46.3%
46.3%
46.3%
46.3%
22ROA
∞%
(6.8)%
(21.8)%
(5.4)%
0.1%
(39.7)%
(37.4)%
(36.8)%
-
-
-
-
-
-
-
23ROE
∞%
(9.5)%
(51)%
(10.5)%
0.1%
(145.7)%
(1,801.7)%
385.5%
-
-
-
-
-
-
-
24Interest coverage
-
-
-
-
-
-
-
(3.2)
-
-
-
-
-
-
-
25Dividend Yield
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
26P/E Ratio
-
-
-
-
-
-
-
(10.7)
-
-
-
-
-
-
-
27Stock price range
-
-
10-11
6-11
1-10
0-3
0-2
0-5
-
-
-
-
-
-
-
28Market Cap
Help
End of Period Market CapLearn more
625.1
625.1
638.5
645.7
120.1
150.4
23.2
3,289
26.8%
(1,381)
(1,513)
(1,657)
(1,815)
(1,990)
-
29FCF Yield
-
-
-
-
-
-
-
(5.2)%
∞%
3.4%
3.9%
4.4%
5%
5.6%
-
30Average stock price
-
-
10.3
8.7
5.4
1.5
1.2
2.5
(24.5)%
(1)
(0.8)
(0.6)
(0.4)
(0.3)
-
31 CEO
DM
Dr. Daniel Virnich FACHE, M.B.A., M.D.
DV
Daniel Virnich